CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
6-minute walking test +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04750148
NCT04750148N/ACompleted
CompareCT.gov

Comparison of the 2MWT, the 10MeWT and the 6MWT in Individuals With Cancer, a Validation Observational Study.

Aline Reinmann·observational·Posted Feb 11, 2021·Updated Jan 4, 2023

In Brief

An observational study evaluating 6-minute walking test, 2-minute walking test, and 2 other interventions for Cancer. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The aim of this study is to assess the feasibility and the validity of the 2-minute walk test (2MWT) and the 10-meter walk test (10MeWT) compared to the 6-minute walk test (6MWT) for subjects with onco-hematological disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 11, 2021
Enrollment StartFeb 15, 2021
Primary CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.4 years ago

Interventions

6-minute walking testother

The subject walks as far as possible for 6 minutes along a 30m long corridor.

2-minute walking testother

The subject walks as far as possible for 2 minutes along a 30m long corridor.

10-meter walk testother

The natural and fast walking speeds of the subject are measured over 10m. This speed is measured by the examiner as well as by the subject (self-tested version).

One leg stance testother

The time held in unipodal equilibrium is measured by the examiner.